ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

ClinicalTrials.gov ID: NCT00009945

Public ClinicalTrials.gov record NCT00009945. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Trial Comparing Adjuvant Clodronate Therapy vs Placebo in Early-Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Hormonal Therapy or No Therapy

Study identification

NCT ID
NCT00009945
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NSABP Foundation Inc
Network
Enrollment
3,323 participants

Conditions and interventions

Conditions

Interventions

  • clodronate Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2000
Primary completion
Feb 28, 2011
Completion
Nov 30, 2012
Last update posted
Dec 12, 2017

2001 – 2012

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale Arizona 85259-5404
Mayo Clinic Jacksonville Florida 32224
MBCCOP - Hawaii Honolulu Hawaii 96813
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
Veterans Affairs Medical Center - Biloxi Biloxi Mississippi 39531-2410
Medcenter One Health System Bismarck North Dakota 58501-5505
Altru Cancer Center Grand Forks North Dakota 58201
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001
Rapid City Regional Hospital Rapid City South Dakota 57709
University of Tennessee Cancer Institute Memphis Tennessee 38103
Danville Radiation Therapy Center Memphis Tennessee 38104
Harrington Cancer Center Amarillo Texas 79106
Veterans Affairs Medical Center - Amarillo Amarillo Texas 79106
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401
MBCCOP - Massey Cancer Center Richmond Virginia 23298-0037
University of Washington School of Medicine Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00009945, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2017 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00009945 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →